ZNF106 is an RNA-binding protein that specifically recognizes 5'-GGGGCC-3' sequence repeats and plays critical roles in neuromuscular and metabolic homeostasis. In skeletal muscle and motor neurons, ZNF106 is essential for maintaining neuromuscular junction integrity and motor neuron survival 1. The protein functions as a splicing regulator by associating with core splicing factor RBM39 and localizing to nuclear speckles 1. Knockout studies demonstrate that ZNF106 loss causes progressive ataxia, hindlimb paralysis, severe muscle wasting, and motor neuron degeneration, with altered splicing of the Nogo (Rtn4) gene resulting in ectopic NOGO-A expression that inhibits nerve regeneration 1. Beyond neuromuscular function, ZNF106 contributes to normal mitochondrial respiratory function in motor neurons through mechanisms yet to be defined. Clinically, ZNF106 variants are associated with multiple disease contexts: the rs12440118 variant is overrepresented in acute pancreatitis patients with early multiple-organ failure 2, and ZNF106 is part of a six-gene prognostic signature predictive of esophageal cancer prognosis and chemotherapy sensitivity 3. Additionally, ZNF106 variants are associated with type 2 diabetes progression in Korean populations 4. These findings position ZNF106 as a multifunctional regulator bridging neuromuscular integrity with broader systemic disease susceptibility.